Learn About Poliomyelitis

What is the definition of Poliomyelitis?
Poliomyelitis is a viral disease that can affect nerves and can lead to partial or full paralysis. It is caused by infection with the poliovirus which can be spread by direct person-to-person contact, by contact with infected mucus or phlegm from the nose or mouth, or by contact with infected feces. There are three basic patterns of polio infection: subclinical infections, nonparalytic, and paralytic. Symptoms vary based on the pattern of infection and can range from asymptomatic with subclinical Poliomyelitis to partial or full paralysis. Since the development of the polio vaccine, the incidence of the disease has been greatly reduced.
What are the alternative names for Poliomyelitis?
  • Poliomyelitis
  • Infantile paralysis
  • Polio
Who are the top Poliomyelitis Local Doctors?
Roland W. Sutter
Elite in Poliomyelitis
Elite in Poliomyelitis
Geneve, GE, CH 

Roland Sutter practices in Geneve, Switzerland. Mr. Sutter is rated as an Elite expert by MediFind in the treatment of Poliomyelitis. His top areas of expertise are Myelitis, Poliomyelitis, Primary Immunodeficiency (PID), and Common Variable Immune Deficiency.

Elite in Poliomyelitis
Elite in Poliomyelitis
Norfolk Place, 
London, ENG, GB 

Nicholas Grassly practices in London, United Kingdom. Mr. Grassly is rated as an Elite expert by MediFind in the treatment of Poliomyelitis. His top areas of expertise are Poliomyelitis, Myelitis, Typhoid Fever, and Salmonella Enterocolitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Poliomyelitis
Elite in Poliomyelitis
8/2 Trubetskaya Str, 
Moscow, MOW, RU 

Liubov Kozlovskaya practices in Moscow, Russian Federation. Kozlovskaya is rated as an Elite expert by MediFind in the treatment of Poliomyelitis. Their top areas of expertise are Poliomyelitis, Myelitis, Omsk Hemorrhagic Fever, and Kyasanur Forest Disease.

What are the latest Poliomyelitis Clinical Trials?
A Randomized, Phase II/III Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

Summary: Phase II/III multicenter, randomized, double-blind, placebo-controlled trial on acetyl-L-carnitine (ALCAR) in subjects living with amyotrophic lateral sclerosis (ALS). Primary study aim: The clinical objective consists of assessing the efficacy of ALCAR (two different dosages will be tested: 1.5g/day and 3g/day) on the progression of functional disability (loss of self-sufficiency), as measured by...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

Summary: The purpose of this study is to determine the safety and feasibility of administering the Tetanus Diptheria Vaccine (Td) or Polio Boost Immunization (IPOL) to patients with metastatic melanoma who are receiving immune checkpoint inhibitor (IO) therapy per standard of care. Subjects will have the vaccine at cycle 4 of IO therapy and will have research blood and tissue samples collected prior to sta...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center